Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 1
2020 5
2021 3
2022 2
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Differential Sensitivity to Ionizing Radiation in Gemcitabine-Resistant and Paclitaxel-Resistant Pancreatic Cancer Cells.
Che PP, Gregori A, Bergonzini C, Ali M, Mantini G, Schmidt T, Finamore F, Rodrigues SMF, Frampton AE, McDonnell LA, Danen EH, Slotman BJ, Sminia P, Giovannetti E. Che PP, et al. Among authors: gregori a. Int J Radiat Oncol Biol Phys. 2024 Apr 1;118(5):1328-1343. doi: 10.1016/j.ijrobp.2023.10.035. Epub 2023 Oct 31. Int J Radiat Oncol Biol Phys. 2024. PMID: 37914140
Prognostic Significance of Integrin Subunit Alpha 2 (ITGA2) and Role of Mechanical Cues in Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma (PDAC).
Gregori A, Bergonzini C, Capula M, Mantini G, Khojasteh-Leylakoohi F, Comandatore A, Khalili-Tanha G, Khooei A, Morelli L, Avan A, Danen EH, Schmidt T, Giovannetti E. Gregori A, et al. Cancers (Basel). 2023 Jan 19;15(3):628. doi: 10.3390/cancers15030628. Cancers (Basel). 2023. PMID: 36765586 Free PMC article.
ABCB1 overexpression through locus amplification represents an actionable target to combat paclitaxel resistance in pancreatic cancer cells.
Bergonzini C, Gregori A, Hagens TMS, van der Noord VE, van de Water B, Zweemer AJM, Coban B, Capula M, Mantini G, Botto A, Finamore F, Garajova I, McDonnell LA, Schmidt T, Giovannetti E, Danen EHJ. Bergonzini C, et al. Among authors: gregori a. J Exp Clin Cancer Res. 2024 Jan 2;43(1):4. doi: 10.1186/s13046-023-02879-8. J Exp Clin Cancer Res. 2024. PMID: 38163893 Free PMC article.
A bug in the resistance to EGFR inhibitors: is there a role for Mycoplasma and cytidine deaminase in reducing the activity of osimertinib in lung cancer patients?
Leonetti A, Carbone D, Gregori A, Tiseo M, Peters GJ, Deng D, Giovannetti E. Leonetti A, et al. Among authors: gregori a. J Cancer Res Clin Oncol. 2021 Oct;147(10):3135-3137. doi: 10.1007/s00432-021-03647-x. Epub 2021 Apr 26. J Cancer Res Clin Oncol. 2021. PMID: 33900435 No abstract available.
Biodegradable Ultrasmall-in-Nano Architectures Loaded with Cisplatin Prodrug in Combination with Ionizing Radiation Induces DNA Damage and Apoptosis in Pancreatic Ductal Adenocarcinoma.
Che PP, Mapanao AK, Gregori A, Ermini ML, Zamborlin A, Capula M, Ngadimin D, Slotman BJ, Voliani V, Sminia P, Giovannetti E. Che PP, et al. Among authors: gregori a. Cancers (Basel). 2022 Jun 20;14(12):3034. doi: 10.3390/cancers14123034. Cancers (Basel). 2022. PMID: 35740699 Free PMC article.
14 results